Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3077% below fair value
$3.16−0.23 (-6.78%)
Close on Nov 17, 2026Market cap $59.40MP/E –Yield –
Outset Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Outset Medical's revenue for the twelve months ending Jun 30, 2026 was $117.80M, down 1.3% year over year. For fiscal 2025 it was $119.48M, up 5.1% from the year before. The highest annual figure on record is $130.38M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $119.48M | +5.1% |
| FY2024 | Dec 31, 2024 | $113.69M | -12.8% |
| FY2023 | Dec 31, 2023 | $130.38M | +13.0% |
| FY2022 | Dec 31, 2022 | $115.38M | +12.4% |
| FY2021 | Dec 31, 2021 | $102.60M | +105.5% |
| FY2020 | Dec 31, 2020 | $49.94M | +231.2% |
| FY2019 | Dec 31, 2019 | $15.08M | +651.3% |
| FY2018 | Dec 31, 2018 | $2.01M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $31.64M | +0.7% |
| Q1 FY2026 | Mar 31, 2026 | $27.86M | -6.3% |
| Q4 FY2025 | Dec 31, 2025 | $28.87M | -2.0% |
| Q3 FY2025 | Sep 30, 2025 | $29.43M | +2.7% |
| Q2 FY2025 | Jun 30, 2025 | $31.42M | +14.7% |
| Q1 FY2025 | Mar 31, 2025 | $29.75M | +5.6% |
| Q4 FY2024 | Dec 31, 2024 | $29.47M | -3.4% |
| Q3 FY2024 | Sep 30, 2024 | $28.67M | -5.6% |
| Q2 FY2024 | Jun 30, 2024 | $27.39M | -24.0% |
| Q1 FY2024 | Mar 31, 2024 | $28.17M | -15.8% |
| Q4 FY2023 | Dec 31, 2023 | $30.51M | -4.7% |
| Q3 FY2023 | Sep 30, 2023 | $30.36M | +9.4% |
| Q2 FY2023 | Jun 30, 2023 | $36.04M | +43.8% |
| Q1 FY2023 | Mar 31, 2023 | $33.47M | +9.5% |
| Q4 FY2022 | Dec 31, 2022 | $32.01M | +13.7% |
| Q3 FY2022 | Sep 30, 2022 | $27.76M | +5.5% |
| Q2 FY2022 | Jun 30, 2022 | $25.06M | -0.6% |
| Q1 FY2022 | Mar 31, 2022 | $30.55M | +33.3% |
| Q4 FY2021 | Dec 31, 2021 | $28.15M | +63.2% |
| Q3 FY2021 | Sep 30, 2021 | $26.32M | +91.3% |
| Q2 FY2021 | Jun 30, 2021 | $25.22M | +114.8% |
| Q1 FY2021 | Mar 31, 2021 | $22.92M | +218.7% |
| Q4 FY2020 | Dec 31, 2020 | $17.25M | +143.4% |
| Q3 FY2020 | Sep 30, 2020 | $13.76M | +423.0% |
| Q2 FY2020 | Jun 30, 2020 | $11.74M | +308.8% |
| Q1 FY2020 | Mar 31, 2020 | $7.19M | +188.6% |
| Q4 FY2019 | Dec 31, 2019 | $7.09M | – |
| Q3 FY2019 | Sep 30, 2019 | $2.63M | – |
| Q2 FY2019 | Jun 30, 2019 | $2.87M | – |
| Q1 FY2019 | Mar 31, 2019 | $2.49M | – |
See a number that looks wrong?